{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": {
    "pdf_name": "CDC_Influenza_vaccines",
    "source_pdf": "data/clinical_files/CDC Influenza vaccines.pdf",
    "total_pages": 2,
    "total_blocks": 23,
    "total_characters": 2237
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 2,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "RIV4 (recombinant HA vaccine)",
      "relevance_explanation": "This quote identifies RIV4 as a recombinant HA vaccine, which directly supports the claim that Flublok is produced using a recombinant technology platform."
    },
    {
      "id": 2,
      "quote": "HA = hemagglutinin; IIV4 = inactivated influenza vaccine, quadrivalent; ... RIV4 (recombinant HA vaccine)",
      "relevance_explanation": "This quote defines RIV4 as a recombinant hemagglutinin vaccine, supporting the claim that Flublok is produced by expressing recombinant HA, which is a key part of the novel production platform described."
    }
  ],
  "model_used": "gpt-4.1"
}